DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 967 filers reported holding DANAHER CORPORATION in Q2 2015. The put-call ratio across all filers is 0.93 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,283,000 | +2.6% | 35,941 | +0.7% | 0.43% | +1.4% |
| Q2 2022 | $9,050,000 | -13.1% | 35,699 | +0.6% | 0.43% | -5.8% |
| Q1 2022 | $10,411,000 | -10.6% | 35,492 | +0.3% | 0.45% | -19.3% |
| Q4 2021 | $11,641,000 | +5.5% | 35,382 | -2.4% | 0.56% | -8.3% |
| Q3 2021 | $11,033,000 | +12.8% | 36,239 | -0.6% | 0.61% | +8.7% |
| Q2 2021 | $9,784,000 | +20.5% | 36,460 | +1.1% | 0.56% | +1.4% |
| Q1 2021 | $8,117,000 | +1.7% | 36,063 | +0.4% | 0.55% | -2.5% |
| Q4 2020 | $7,978,000 | +1.4% | 35,913 | -1.7% | 0.57% | -10.1% |
| Q3 2020 | $7,869,000 | +12.3% | 36,543 | -7.8% | 0.63% | +7.5% |
| Q2 2020 | $7,010,000 | +24.9% | 39,641 | -2.2% | 0.59% | +8.7% |
| Q1 2020 | $5,613,000 | -12.4% | 40,553 | -2.9% | 0.54% | +10.0% |
| Q4 2019 | $6,410,000 | +6.9% | 41,762 | +0.6% | 0.49% | -0.8% |
| Q3 2019 | $5,998,000 | +1.9% | 41,528 | +0.8% | 0.50% | +1.6% |
| Q2 2019 | $5,889,000 | +6.5% | 41,202 | -1.7% | 0.49% | -8.3% |
| Q1 2019 | $5,532,000 | +23.6% | 41,904 | +2.5% | 0.53% | +14.7% |
| Q4 2018 | $4,477,000 | +2.4% | 40,869 | +1.6% | 0.46% | +21.5% |
| Q3 2018 | $4,373,000 | +8.8% | 40,245 | -1.2% | 0.38% | +2.4% |
| Q2 2018 | $4,020,000 | +2.3% | 40,735 | +1.4% | 0.37% | +1.4% |
| Q1 2018 | $3,931,000 | +3.1% | 40,153 | -2.2% | 0.37% | +7.0% |
| Q4 2017 | $3,811,000 | +8.5% | 41,053 | +0.2% | 0.34% | -3.6% |
| Q3 2017 | $3,514,000 | +1.5% | 40,963 | -0.1% | 0.36% | -2.2% |
| Q2 2017 | $3,461,000 | +0.6% | 41,007 | +1.9% | 0.36% | -0.5% |
| Q1 2017 | $3,441,000 | +11.8% | 40,229 | +1.8% | 0.37% | +6.7% |
| Q4 2016 | $3,077,000 | +0.5% | 39,534 | +1.2% | 0.34% | -3.9% |
| Q3 2016 | $3,063,000 | -19.3% | 39,078 | +4.0% | 0.36% | -21.5% |
| Q2 2016 | $3,795,000 | +8.6% | 37,573 | +2.0% | 0.46% | +5.8% |
| Q1 2016 | $3,495,000 | +5.7% | 36,845 | +3.6% | 0.43% | +3.6% |
| Q4 2015 | $3,305,000 | +6.8% | 35,581 | -2.0% | 0.42% | -1.2% |
| Q3 2015 | $3,094,000 | -0.6% | 36,310 | -0.2% | 0.42% | +7.4% |
| Q2 2015 | $3,114,000 | +2.4% | 36,386 | +1.6% | 0.39% | +3.2% |
| Q1 2015 | $3,041,000 | -5.0% | 35,823 | -4.1% | 0.38% | -4.8% |
| Q4 2014 | $3,202,000 | +13.9% | 37,357 | +1.0% | 0.40% | +7.8% |
| Q3 2014 | $2,811,000 | -3.6% | 36,999 | -0.1% | 0.37% | -1.9% |
| Q2 2014 | $2,916,000 | +0.1% | 37,039 | -4.7% | 0.38% | -1.8% |
| Q1 2014 | $2,914,000 | -1.1% | 38,854 | +1.9% | 0.38% | -7.2% |
| Q4 2013 | $2,945,000 | +15.0% | 38,142 | +3.3% | 0.41% | +3.2% |
| Q3 2013 | $2,560,000 | +8.4% | 36,934 | -1.0% | 0.40% | +2.0% |
| Q2 2013 | $2,362,000 | – | 37,321 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |